Prothena Corp PLC (PRTA)
11.48
-0.25 -2.13%
NASDAQ
Nov 23, 16:59
USD
Prothena Revenue (Quarterly):
0.157M for Sept. 30, 2020View 4,000+ financial data types
Browse...
View Full Chart
Revenue (Quarterly) Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Historical Revenue (Quarterly) Data
View and export this data going back to 2012.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| Sept. 30, 2020 | 0.157M |
| June 30, 2020 | 0.195M |
| March 31, 2020 | 0.141M |
| Dec. 31, 2019 | 0.256M |
| Sept. 30, 2019 | 0.205M |
| June 30, 2019 | 0.167M |
| March 31, 2019 | 0.186M |
| Dec. 31, 2018 | 0.194M |
| Sept. 30, 2018 | 0.255M |
| June 30, 2018 | 0.279M |
| March 31, 2018 | 0.227M |
| Dec. 31, 2017 | 0.229M |
| Sept. 30, 2017 | 0.219M |
| June 30, 2017 | 26.81M |
| March 31, 2017 | 0.259M |
| Dec. 31, 2016 | 0.171M |
| Sept. 30, 2016 | 0.286M |
| June 30, 2016 | 0.333M |
| March 31, 2016 | 0.265M |
| Dec. 31, 2015 | 0.307M |
| Sept. 30, 2015 | 0.429M |
| June 30, 2015 | 0.278M |
| March 31, 2015 | 0.593M |
| Dec. 31, 2014 | 2.013M |
| Sept. 30, 2014 | 1.486M |
| June 30, 2014 | 15.12M |
| March 31, 2014 | 32.23M |
| Dec. 31, 2013 | 0.167M |
| Sept. 30, 2013 | 0.171M |
| June 30, 2013 | 0.167M |
| March 31, 2013 | 0.171M |
| Dec. 31, 2012 | 0.575M |
| Sept. 30, 2012 | 0.944M |
| June 30, 2012 | 0.735M |
| March 31, 2012 | 0.404M |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
Advertisement
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Benchmarks
| Alkermes PLC | 265.01M |
| Amarin Corp PLC | 156.50M |
| Jazz Pharmaceuticals PLC | 600.89M |
Revenue (Quarterly) Range, Past 5 Years
| Minimum | 0.141M | Mar 2020 |
| Maximum | 26.81M | Jun 2017 |
| Average | 1.557M |
News
Here's Why We're Not Too Worried About Prothena's (NASDAQ:PRTA) Cash Burn Situation
Yahoo 11/16 02:56 ET
Yahoo 11/16 02:56 ET
--Analyst Actions: Oppenheimer Adjusts Prothena PT to $20 From $18, Maintains Outperform Rating
MT Newswires 11/05 12:23 ET
MT Newswires 11/05 12:23 ET
-- Earnings Flash (PRTA) PROTHENA CORPORATION Reports Q3 Revenue $157,000, vs. Street Est of $0.193M
MT Newswires 11/04 16:41 ET
MT Newswires 11/04 16:41 ET
Prothena Reports Third Quarter 2020 Financial Results and Provides R&D Update
Globe Newswire 11/04 16:05 ET
Globe Newswire 11/04 16:05 ET
Prothena Announces Presentations on Two Programs from its Alzheimer’s Disease Portfolio at CTAD 2020
Globe Newswire 11/04 08:30 ET
Globe Newswire 11/04 08:30 ET
Advertisement
